March 24, 2014
/PRNewswire/ -- Securities lawyers at
Deans & Lyons
announce an investigation of the board of Geron Corporation (NASDAQ: GERN). Concerned GERN investors who purchased between
June 16, 2013
March 11, 2014
are encouraged to contact securities attorney Hamilton Lindley by
March 12, 2014
announcement that the FDA put Geron's Investigational New Drug application for imetelstat on full clinical hold, stock plummeted more than 60%," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed to Geron Corporation shareholders."
Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. GERN stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at
or 877-819-8033 with questions or concerns.
Hamilton Lindley DEANS & LYONS LLP 325 North Saint Paul Street, Suite 1500
75201 Phone: 214-736-7861 Fax: 214-965-8505 Toll-free: 877-819-8033
SOURCE Deans & Lyons LLP